Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

biotech

GRTS stock

Relmada Therapeutics Inc. (RLMD) Stock Continues Downward Trend Despite Promising Top-line Data from REL-1017 Study

Relmada Therapeutics Inc. (RLMD) stock prices were down 3.26% some time after market trading commenced on July 27th, 2021, bringing the price per share down to USD$24.30 early on in the trading day. Positive REL-1017 Topline Data July 27th 2021 announced the top-line results of the human abuse potential study with REL-1017, the company’s lead …

Relmada Therapeutics Inc. (RLMD) Stock Continues Downward Trend Despite Promising Top-line Data from REL-1017 Study Read More »

Serum

Lexaria Bioscience Corp. (LEXX) Stock Showing Increased Volatility Ahead of Success of Antiviral Drug Studies

Lexaria Bioscience Corp. (LEXX) stock prices soared by 28.07% at the end of the trading day on July 21st, 2021, bringing the price per share up to USD$8.44 at the end of the trading day. Subsequent premarket fluctuations have seen the stock fall by 11.14%, bringing it down to USD$7.50. DehydraTECH Evaluation The company reported …

Lexaria Bioscience Corp. (LEXX) Stock Showing Increased Volatility Ahead of Success of Antiviral Drug Studies Read More »

TBIO Stock

Trinity Biotech PLC (TRIB) Stock Surges Higher Following Announcement of Proliferation of Covid-19 Testing Space

Trinity Biotech PLC (TRIB) stock prices were up 11.70% shortly after market trading commenced on July 16th, 2021, bringing the price per share up to USD$2.229 early on in the trading day. Rapid Antigen Test The company reported being at an advanced stage in the development of an antigen test for the coronavirus that has …

Trinity Biotech PLC (TRIB) Stock Surges Higher Following Announcement of Proliferation of Covid-19 Testing Space Read More »

Livepeer

Vyant Bio, Inc. (VYNT) Stock Undergoes Minor Volatility Ahead of Granting of US Patent for iPSCs

Vyant Bio, Inc. (VYNT) stock prices were down by 5.22% at the end of the trading day on July 14th, 2021, bringing the price per share down to USD$3.27 at the end of the trading day. Subsequent premarket fluctuations have seen the stock recover by 5.81%, bringing it up to USD$3.46. StemoniX Granted US Patent …

Vyant Bio, Inc. (VYNT) Stock Undergoes Minor Volatility Ahead of Granting of US Patent for iPSCs Read More »

NNVC Stock

Qualigen Therapeutics, Inc. (QLGN) Stock on the Rise Following IND Submission for Novel Covid-19 Treatment, QN-165

Qualigen Therapeutics, Inc. (QLGN) stock prices were up 1.6854% as of the market opening on July 14th, 2021, with premarket trading having seen the stock rise sharply. As of writing, the price per share of QLGN stock was USD$1.81. IND Submission July 14th, 2021 saw the biotechnology company announce the submission of an Investigational New …

Qualigen Therapeutics, Inc. (QLGN) Stock on the Rise Following IND Submission for Novel Covid-19 Treatment, QN-165 Read More »

JWEL Stock

INmune Bio, Inc. (INMB) Stock on the Rise Following First Patient Treatment in INKmune Phase 1 Clinical Trial

INmune Bio, Inc. (INMB) stock prices were up by 12.67% as of the market closing on July 13th, 2021, bringing the price per share up to USD$26.68. Subsequent premarket fluctuations saw the stock rise by 7.01%, bringing it up to USD$28.55. INKmune July 12th, 2021 saw the company announce the use of INKmune, its Natural …

INmune Bio, Inc. (INMB) Stock on the Rise Following First Patient Treatment in INKmune Phase 1 Clinical Trial Read More »

VNCE stock

Origin Agritech Ltd. (SEED) Stock Surges Following Expansion of GMO Trait Portfolio

Origin Agritech Ltd. (SEED) stock prices were up by 29.22% some time after market trading commenced on July 12th, 2021, bringing the price per share up to USD$11.63 early on in the trading day. Exclusive Rights Agreement July 12th, 2021 saw the company announce that it had entered into an exclusive rights agreement with the …

Origin Agritech Ltd. (SEED) Stock Surges Following Expansion of GMO Trait Portfolio Read More »

Gnosis

Advaxis, Inc. (ADXS) Stock Skyrockets Ahead of Definitive Merger Agreement with Biosight Ltd

Advaxis, Inc. (ADXS) stock prices skyrocketed by a massive 41.25% shortly after market trading commenced on July 6th, 2021, bringing it up to USD$0.667 early on in the trading day. Merger with Biosight July 6th, 2021 saw the company announce its definitive merger agreement with Biosight Ltd, which will see shareholders of Biosight become majority …

Advaxis, Inc. (ADXS) Stock Skyrockets Ahead of Definitive Merger Agreement with Biosight Ltd Read More »

HJLI STOCK

Larimar Therapeutics, Inc. (LRMR) Stock on the Rise as Resolution of FDA Clinical Hold Continues to Develop

Larimar Therapeutics, Inc. (LRMR) stock prices were up by a marginal 1.54% as of the market closing on July 2nd, 2021, bringing the price per share up to USD$9.89 at the end of the trading day. After hours trading saw the stock surge by 10.21%, bringing it up to USD$10.90. Clinical Hold for CTI-1601 May …

Larimar Therapeutics, Inc. (LRMR) Stock on the Rise as Resolution of FDA Clinical Hold Continues to Develop Read More »

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam